The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life (QoL) benefits following 177Lu-DOTATATE therapy in patients (pts) with 68Ga-DOTATATE PET positive primary site agnostic neuroendocrine tumors (NET).
 
Rebecca KS Wong
Honoraria - Elekta (Inst); Novartis
Research Funding - Bruce Power (Inst); Celgene/Bristol-Myers Squibb (Inst); POINT Biopharma (Inst); Precirix (Inst)
 
Sten Myrehaug
Honoraria - Advanced Accelerator Applications; Ipsen
Research Funding - Ipsen
 
Rosalyn A. Juergens
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Oncology; Jazz Pharmaceuticals; Merck Sharp & Dohme; Mirati Therapeutics; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche Canada; Sanofi; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; EMD Serono; Fusion Pharmaceuticals; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche Canada; Sanofi/Regeneron; Takeda
Research Funding - Alkermes (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bold Therapeutics (Inst); Bristol-Myers Squibb (Inst); Fusion Pharmaceuticals (Inst); Janssen (Inst); Macrogenics (Inst); Merck Sharp & Dohme (Inst); mirai (Inst); Novartis (Inst); Pfizer (Inst)
 
David Laidley
Consulting or Advisory Role - Bayer; Ipsen; Novartis Canada Pharmaceuticals Inc
Research Funding - Novartis (Inst); POINT Biopharma (Inst)
 
Shereen Ezzat
No Relationships to Disclose
 
Jean-Mathieu Beauregard
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Novartis Canada Pharmaceuticals Inc
Research Funding - Ipsen (Inst); Novartis (Inst); Point Biopharma (Inst)
 
Oren Hannun Levine
Honoraria - Merck
 
Patrick Veit-Haibach
No Relationships to Disclose
 
Ur Metser
Employment - POINT Biopharma
Consulting or Advisory Role - POINT Biopharma
 
Brandon Driscoll
No Relationships to Disclose
 
Andrea Shessel
No Relationships to Disclose
 
Ivan Yeung
No Relationships to Disclose
 
Aruz Mesci
No Relationships to Disclose
 
Julia Publicover
No Relationships to Disclose
 
Edward Sun
No Relationships to Disclose
 
Katherine Lajkosz
No Relationships to Disclose